Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus.

Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age.

August 16, 2022

Reiteration and Further Guidance on the Reporting of COVID-19 Vaccination Coverage from National Government Agencies

September 1, 2022

Concerns regarding the Utilization of Pfizer Vaccine for Pediatric Population 5 to 11 Years Old, Administration of Second Booster among Pregnant Women and Vaccine Contingeny Plan During Emergencies, Disasters and Other Crisis Situation

September 2, 2022

(Amended Version) Advisory on Updated Shelf Life of Pfizer-BioNtech (Orange Cap) mRNA COVID-19 Vaccines

September 8, 2022

Reconstitution of the National Vaccination Operations Center (NVOC) as Public Health Operation Center (PHOC)

September 9, 2022

“Updates on the Requirements for the Administration of COVID-19 Booster Doses”

September 14, 2022

Bakunahang Bayan: PinasLakas Special Vaccination Days : Reiteration of the Targets for the First 100 Days and Introduction to the Toolkit

September 14, 2022

Clarifications on the Advisory No. 14 pertainingg to the Administration of Second COVID-19 Vooster among Pregnant Women

September 26, 2022

Resumption of Bakunahangg Bayan: PinasLakas Special Vaccination Days Activities

September 27, 2022

Advisory on Shelf Life Extension of COVID-19 Vaccines

September 28, 2022

Updates on the COVID-19 Vaccination Targets

September 30, 2022

Clarifications regarding the Circulating Unofficial Advisory on the temporary Quarantine of Selected Pediatric Pfizer Doses

October 13, 2022

Recommendation for the Administration of Heterologous Primary Series for 12-17 Years Old Pediatric Population